European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - bosutinib (as monohydrate) - leukemia, myeloid - antineoplastic agents, protein kinase inhibitors - bosulif is indicated for the treatment of adult patients with:newly‑diagnosed chronic phase (cp) philadelphia chromosome-positive chronic myelogenous leukaemia (ph+ cml).cp, accelerated phase (ap), and blast phase (bp) ph+ cml previously treated with one or more tyrosine kinase inhibitor(s) [tki(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

Canada - English - Health Canada

pfizer canada ulc - bosutinib (bosutinib monohydrate) - tablet - 100mg - bosutinib (bosutinib monohydrate) 100mg - antineoplastic agents

Canada - English - Health Canada

pfizer canada ulc - bosutinib (bosutinib monohydrate) - tablet - 500mg - bosutinib (bosutinib monohydrate) 500mg - antineoplastic agents

Canada - English - Health Canada

pfizer canada ulc - bosutinib (bosutinib monohydrate) - tablet - 400mg - bosutinib (bosutinib monohydrate) 400mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - bosutinib - tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - bosutinib - tablet - 500mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio franco colombiano lafrancol, s.a.s. - bosutinib (monohidrato) - bosutinib (monohidrato)....500,000 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio franco colombiano lafrancol, s.a.s. - bosutinib (monohidrato) - bosutinib (monohidrato)....100 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - bosutinib - tablet - 400mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pfizer europe ma eeig, belgium - bosutinib - film-coated tablet - 100 mg